|
| Author (origin) | Study group | Control | Primary outcome |
|
| Lapolla et al., 2011 (Italy) [31] | 100 g IADPSG-positive, C&C-negative
(fasting: 92–94 mg/dL; 2 h: 153-154 mg/dL; not treated)
| IADPSG-negative
(fasting: <92 mg/dL; 1 h: <180 mg/dL; 2 h: <153 mg/dL)
| Perinatal outcomes |
|
| Bodmer-Roy et al., 2012 (Canada) [32] | 75 g IADPSG-positive, CDA-negative
(fasting: 92–95 mg/dL; 1 h: 180–190 mg/dL; 2 h: 153–159 mg/dL; not treated)
| GCT-negative (50 g 1 h < 137 mg/dL)
Or
IADPSG-negative
(fasting: <92 mg/dL; 1 h: <180 mg/dL; 2 h: <153 mg/dL)
| LGA > 90th percentile |
|
| Benhalima et al., 2013 (Belgium) [33] | 100 g IADPSG-positive, C&C-negative
(fasting: 92–94 mg/dL; 2 h: 153-154 mg/dL; not treated)
| GCT-negative (50 g 1 h < 140 mg/dL)
And
IADPSG-negative
(fasting: <92 mg/dL; 1 h: <180 mg/dL; 2 h: <153 mg/dL)
| Pregnancy outcomes |
|
| Ethridge et al., 2014 (USA) [34] | 100 g IADPSG-positive, C&C-negative
(fasting: 92–94 mg/dL; 2 h: 153-154 mg/dL; not treated)
| GCT-negative (50 g 1 h < 135 mg/dL)
Or
IADPSG-negative
(fasting: <92 mg/dL; 1 h: <180 mg/dL; 2 h: <153 mg/dL)
| Birth weight and neonatal outcomes |
|
| Liao et al., 2014 (China) [35] | 100 g IADPSG-positive, C&C-negative
(fasting: 92–94 mg/dL; 2 h: 153-154 mg/dL; not treated)
| GCT-negative (50 g 1 h < 140 mg/dL)
And
IADPSG-negative
(fasting: <92 mg/dL; 1 h: <180 mg/dL; 2 h: <153 mg/dL)
| Maternal and neonatal outcomes
|
|
| Mayo et al., 2015 (Canada) [36] | 75 g IADPSG-positive, CDA-negative
(fasting: 92–95 mg/dL; 1 h: 180–190 mg/dL; 2 h: 153–159 mg/dL; not treated)
| GCT-negative
(50 g 1 h < 140 mg/dL)
Or
IADPSG-negative
(fasting: <92 mg/dL; 1 h: <180 mg/dL; 2 h: <153 mg/dL)
| Not stated |
|
| Meek et al., 2015 (USA) [37] | 75 g IADPSG-positive, NICE-negative
(fasting: 92–101 mg/dL; 1 h: ≥153 mg/dL; not treated)
| IADPSG-negative
(fasting: <92 mg/dL; 1 h: <180 mg/dL; 2 h: <153 mg/dL)
| Delivery and neonatal outcomes |
|
| Tward et al., 2016 (Canada) [38] | 75 g IADPSG-positive, CDA-negative
(fasting: 92–95 mg/dL; 1 h: 180–190 mg/dL; 2 h: 153–159 mg/dL; not treated)
| GCT-negative
(50 g 1 h < 140 mg/dL)
Or
IADPSG-negative
(fasting: <92 mg/dL; 1 h: <180 mg/dL; 2 h: <153 mg/dL)
| Fetal growth in twins |
|
